Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition
Purpose : To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and n...
Saved in:
Published in | International journal of radiation biology Vol. 78; no. 5; pp. 341 - 346 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Informa UK Ltd
01.05.2002
Taylor & Francis |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose : To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance. Materials and methods : Stimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells. Results : The assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004). Conclusions : The results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers. |
---|---|
AbstractList | To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance. Stimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells. The assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004). The results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers. Purpose : To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance. Materials and methods : Stimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells. Results : The assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004). Conclusions : The results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers. PURPOSETo investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance.MATERIALS AND METHODSStimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells.RESULTSThe assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004).CONCLUSIONSThe results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers. To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies demonstrated an enhanced sensitivity in substantial proportions of patients with breast or colorectal cancer, and in early onset head and neck cancer cases. Heritability of chromosomal radiosensitivity in families of breast cancer patients was also demonstrated. It is suggested that elevated sensitivity in this assay could be a marker of genetic predisposition to cancer, mediated through inherited genetic determinants of low penetrance. Stimulated lymphocytes were exposed to 0.5 Gy X-rays in the G2-phase of the cell cycle and chromatid aberrations were scored in metaphase cells. The assay was performed on 32 patients with early onset cancers (aged 0.5-19 years) of various types and their sensitivity was compared with that of 41 young normal controls (0.25-19 years) and 32 adult normals (20-60 years). The proportion of cases showing enhanced sensitivity in the three groups was 44, 15 and 10%, respectively. The difference between the young patients and normals was highly significant (p = 0.004). The results suggest the possibility that a substantial proportion of early onset cancers are associated with the inheritance of predisposing genes of low penetrance. However, support for this hypothesis requires that the heritability of chromosomal radiosensitivity be demonstrated in family members. In addition, a larger study is now required to investigate the chromosomal radiosensitivity of specific early onset cancers. |
Author | Eden, O. B. West, C. M. Warren, C. Scott, D. Roberts, S. A. Baria, K. |
Author_xml | – sequence: 1 givenname: K. surname: Baria fullname: Baria, K. organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK – sequence: 2 givenname: C. surname: Warren fullname: Warren, C. organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK – sequence: 3 givenname: O. B. surname: Eden fullname: Eden, O. B. organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK – sequence: 4 givenname: S. A. surname: Roberts fullname: Roberts, S. A. organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK – sequence: 5 givenname: C. M. surname: West fullname: West, C. M. organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK – sequence: 6 givenname: D. surname: Scott fullname: Scott, D. organization: 1Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, M20 4BX, UK |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15245022$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12020425$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU2LFDEQhoOsuLOrP8CL5KK30UrS6Q_1IoNfsOBFz02SruxkSSdtkl6Zf2-WGVlEWCGQgvd5i3qrLshZiAEJec7gNYMe3sAgpQAAxurrhBwekQ0TLd-KqpyRzZ1ea-Dn5CLnm0pyEP0Tcs54rRouN0Tv9inOMcdZeZrU5GLGkF1xt64cqAv0ENdwTY0KBhNdVHEYSn5Ll5iz0x4p3roJq0ijpdcYsDhDl4STyxWpfWJ4Sh5b5TM-O_2X5Menj993X7ZX3z5_3X242pqmFWWL0FqQNVCjDehOKz2otgHQTDENggs2SMM4Qz0ADrJnXWftNLGpayaw0opL8urYd0nx54q5jLPLBr1XAeOax451NXTb_Bdkfc8BOllBdgRNqnET2nFJblbpMDIY7y4w_nOB6nlxar7qGad7x2nlFXh5AlQ2yttUV-vyPSd5I4Hzyr0_ci7YmGb1KyY_jUUdfEx_TOKhOd79Zd-j8mVvVMLxJq4p1Es8kOI3mzG1tA |
CitedBy_id | crossref_primary_10_1002_em_20274 crossref_primary_10_1016_j_radonc_2011_09_021 crossref_primary_10_1088_0952_4746_28_1_N01 crossref_primary_10_1002_em_20633 crossref_primary_10_1093_mutage_gen009 crossref_primary_10_1111_j_1365_2141_2004_05166_x crossref_primary_10_1159_000077517 crossref_primary_10_1038_sj_bjc_6604345 crossref_primary_10_1038_sj_bjc_6602807 crossref_primary_10_1093_mutage_ges006 crossref_primary_10_1016_S0360_3016_03_00664_3 crossref_primary_10_3109_09553002_2010_496027 crossref_primary_10_1093_mutage_gei040 crossref_primary_10_1016_j_cancergencyto_2004_05_018 crossref_primary_10_1016_j_mrfmmm_2004_11_002 crossref_primary_10_1007_s10549_011_1940_1 crossref_primary_10_1016_S0167_8140_02_00167_6 crossref_primary_10_1016_j_mrrev_2016_09_001 crossref_primary_10_1093_mutage_ges040 crossref_primary_10_1097_00004032_200307000_00013 crossref_primary_10_3389_fonc_2020_01338 crossref_primary_10_1148_rg_235035040 crossref_primary_10_1667_RR1943_1 crossref_primary_10_1016_j_radonc_2007_04_010 crossref_primary_10_1038_sj_bjc_6604514 crossref_primary_10_1097_01_cej_0000199502_23195_29 crossref_primary_10_1186_2041_9414_1_8 crossref_primary_10_1080_09553000500147642 crossref_primary_10_3109_09553002_2011_622032 crossref_primary_10_1080_09553000500280500 crossref_primary_10_1016_j_mrgentox_2010_03_016 crossref_primary_10_1667_RR14862_1 crossref_primary_10_1038_sj_onc_1206883 |
ContentType | Journal Article |
Copyright | 2002 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2002 2003 INIST-CNRS |
Copyright_xml | – notice: 2002 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2002 – notice: 2003 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U7 8FD C1K FR3 P64 RC3 7X8 |
DOI | 10.1080/09553000110117359 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Engineering Research Database Technology Research Database Toxicology Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Genetics Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Sciences (General) Biology |
EISSN | 1362-3095 |
EndPage | 346 |
ExternalDocumentID | 10_1080_09553000110117359 12020425 15245022 11373383 |
Genre | Research Article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .GJ 00X 03L 0BK 0R~ 29J 36B 4.4 53G 5GY 5RE 5VS 8WZ A6W A8Z AAJNR AALIY AALUX AAMIU AAPUL AAPXX AAQRR AAUGY ABBKH ABDBF ABEIZ ABLKL ABPTK ABUPF ABWCV ABZEW ACENM ACFUF ACGEJ ACGFS ACKZS ACLSK ADCVX ADFCX ADFOM ADFZZ ADRBQ ADXPE AECIN AEIIZ AENEX AEOZL AEXWM AEYQI AFFNX AFKVX AFLEI AFWLO AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJVHN AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AMDAE AWYRJ BABNJ BLEHA BOHLJ BRMBE CAG CCCUG COF CS3 CYYVM CZDIS DKSSO DRXRE DU5 DWTOO EAP EAS EBB EBC EBD EBO EBS EBX EHN EJD EMB EMK EMOBN EPL EPT ESX F5P H13 HZ~ J.N J5H JENTW KRBQP KSSTO KWAYT KYCEM LJTGL M44 M4Z O9- P2P QQXMO Q~Q RNANH RVRKI SV3 TFDNU TFL TFW TH9 TUS UDS UEQFS V1S X7M ZGI ZXP ~1N ABJNI ABLIJ ABMYL ABXYU ESTFP P0W IQODW AAORF ACIEZ ALYBC CGR CUY CVF ECM EIF NPM NUSFT TBQAZ TDBHL TERGH TUROJ AAYXX CITATION 7U7 8FD C1K FR3 P64 RC3 7X8 |
ID | FETCH-LOGICAL-c463t-e06f055534bc0b7bab9a6400b1a1b0323195c121eb90e958177ffdd1d74d0f5f3 |
ISSN | 0955-3002 |
IngestDate | Fri Oct 25 08:27:42 EDT 2024 Thu Oct 24 20:41:15 EDT 2024 Thu Sep 26 16:22:31 EDT 2024 Tue Oct 15 23:25:32 EDT 2024 Sun Oct 22 16:09:28 EDT 2023 Thu Mar 14 07:16:33 EDT 2024 Wed Jun 21 08:15:12 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c463t-e06f055534bc0b7bab9a6400b1a1b0323195c121eb90e958177ffdd1d74d0f5f3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 12020425 |
PQID | 18820075 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | informaworld_taylorfrancis_310_1080_09553000110117359 crossref_primary_10_1080_09553000110117359 pascalfrancis_primary_15245022 informahealthcare_journals_10_1080_09553000110117359 pubmed_primary_12020425 proquest_miscellaneous_71720464 proquest_miscellaneous_18820075 |
PublicationCentury | 2000 |
PublicationDate | 2002-05-01 |
PublicationDateYYYYMMDD | 2002-05-01 |
PublicationDate_xml | – month: 05 year: 2002 text: 2002-05-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | International journal of radiation biology |
PublicationTitleAlternate | Int J Radiat Biol |
PublicationYear | 2002 |
Publisher | Informa UK Ltd Taylor & Francis |
Publisher_xml | – name: Informa UK Ltd – name: Taylor & Francis |
SSID | ssj0002038 |
Score | 1.8701751 |
Snippet | Purpose : To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier... To investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies... PURPOSETo investigate the G2 chromosomal radiosensitivity of patients with cancers diagnosed when the patients are less than 20 years of age. Earlier studies... |
SourceID | proquest crossref pubmed pascalfrancis informaworld informahealthcare |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 341 |
SubjectTerms | Adolescent Adult Age of Onset Biological and medical sciences Case-Control Studies Child Child, Preschool Chromosome Aberrations Chromosomes, Human - genetics Chromosomes, Human - radiation effects Female G2 Phase Humans In Vitro Techniques Infant Lymphocytes - radiation effects Male Medical sciences Middle Aged Neoplasms - genetics Radiation Tolerance - genetics Space life sciences |
Title | Chromosomal radiosensitivity in young cancer patients: possible evidence of genetic predisposition |
URI | https://www.tandfonline.com/doi/abs/10.1080/09553000110117359 https://www.ncbi.nlm.nih.gov/pubmed/12020425 https://search.proquest.com/docview/18820075 https://search.proquest.com/docview/71720464 |
Volume | 78 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJxAvaCu3chl-4AGoEtlxnDS8tWPTxAQ8sEp7i-LEFpVYMqXtw_gv_Fd8YufW0Qn2ElVWkiY6n885Pvn8HYTeTiVTIZfKYYQovUAR0hGR9B3BdK7g0wRiPrAtvganC__zBb8YDH53WEubtXDTX3_dV3IXq-oxbVfYJfsflm1uqgf0b21ffdQW1sd_sjEo214Wq-IS1PmTbFmsgI5u-0Es88k1TGXgdaWyrBVUKwrcVQFT4aecSNtUFHJG_TewoxFkA7Jlw-bqZq_98mFHdAL-3CDJijq1BdLSsHHP3LZ0X5bG1x01Y8fW-31zJ_Nm0JC-K5x9dyczt1eg8Fo6oFm02m1Vi7MOUckUIDkgxPhiadwv7OFixLTdrP1zOO3gkHecLTOSWTZuM1PKvBESLIcygv5IlUIepSGzKuR9pW1ay6Vun3sP7Xnaj02HaG82_zQ_aUK9R6pW6c2r1J_NQbx9-ya9xGffyuL-aEh-W1K5wNFNVnqaKtNfZfcCqEqEzvfRI7uCwTMDxwM0kPkI3Tc9Ta9H6MEXy9YYoQMbOFb4nVU3f_8YiQ5o8TZo8TLHFWixAS2uQfsR15DFNWRxobCFLO5D9glanByfH506ttGHk_oBWzuSBAqE55gvUiJCkYgoCXRwETShgjC9BIl4Sj0qRURkxKc0DJXKMpqFfkYUV-wpGuZFLp8jnAkaRAp0BVniq0AknvJIFojIy0RCWDhGH2orxFdGzyXeafcx8m_YKbaTa3XbZbxrynhd1d6sIWN2y3WHPZu3D8g9n-tke4ze1CCIdRSAT3tJLouNfha9UIbsf_cZIYV2VIE_Rs8Metq7e7BB3uMv7va2L9HDdta_QsN1uZGvdaK-Fod2uvwBR9jhww |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chromosomal+radiosensitivity+in+young+cancer+patients%3A+possible+evidence+of+genetic+predisposition&rft.jtitle=International+journal+of+radiation+biology&rft.au=Baria%2C+K.&rft.au=Warren%2C+C.&rft.au=Eden%2C+O.+B.&rft.au=Roberts%2C+S.+A.&rft.date=2002-05-01&rft.pub=Informa+UK+Ltd&rft.issn=0955-3002&rft.eissn=1362-3095&rft.volume=78&rft.issue=5&rft.spage=341&rft.epage=346&rft_id=info:doi/10.1080%2F09553000110117359&rft.externalDocID=10_1080_09553000110117359 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0955-3002&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0955-3002&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0955-3002&client=summon |